<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://dspace.bsuedu.ru/handle/123456789/62342">
    <title>DSpace Collection:</title>
    <link>http://dspace.bsuedu.ru/handle/123456789/62342</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://dspace.bsuedu.ru/handle/123456789/62669" />
        <rdf:li rdf:resource="http://dspace.bsuedu.ru/handle/123456789/62667" />
        <rdf:li rdf:resource="http://dspace.bsuedu.ru/handle/123456789/62664" />
        <rdf:li rdf:resource="http://dspace.bsuedu.ru/handle/123456789/62662" />
      </rdf:Seq>
    </items>
    <dc:date>2026-04-07T13:54:15Z</dc:date>
  </channel>
  <item rdf:about="http://dspace.bsuedu.ru/handle/123456789/62669">
    <title>Antibiotic resistance of infectious agents associated with prior hospitalization</title>
    <link>http://dspace.bsuedu.ru/handle/123456789/62669</link>
    <description>Title: Antibiotic resistance of infectious agents associated with prior hospitalization
Authors: Perfileva, D. Yu.; Miroshnichenko, A. G.; Kulikov, E. S.; Perfilev, V. Yu.; Boykov, V. A.
Abstract: One of the frequent causes of re-hospitalization is infectious complications due to previous colonization of patient loci by microorganisms circulating in the hospital environment. In the conditions of real clinical practice among hospital-acquired infections (HAI), it is advisable to distinguish a special group of diseases - infections associated with previous hospitalization (IPAH)</description>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://dspace.bsuedu.ru/handle/123456789/62667">
    <title>The effect of dalargin on growth factors content in experimental ulcerative colitis</title>
    <link>http://dspace.bsuedu.ru/handle/123456789/62667</link>
    <description>Title: The effect of dalargin on growth factors content in experimental ulcerative colitis
Authors: Liashev, A. Yu.; Mal, G. S.; Solin, A. V.; Balanina, M. A.
Abstract: The aim of the study was to evaluate the dalargin effect on the content of transforming growth factor-β (TGF-β) and epidermal growth factor (EGF) in the colonic wall in mice with experimental ulcerative colitis</description>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://dspace.bsuedu.ru/handle/123456789/62664">
    <title>Identification and synthesis of metabolites of the new antiglaucoma drug</title>
    <link>http://dspace.bsuedu.ru/handle/123456789/62664</link>
    <description>Title: Identification and synthesis of metabolites of the new antiglaucoma drug
Authors: Khokhlov, A. L.; Yaichkov, I. I.; Korsakov, M. K.; Shetnev, A. A.; Ivanovskiy, S. A.
Abstract: The determination of biotransformation products is an essential part of the preclinical trial of original medicines. These studies have not been conducted before for the new drug 5-[5- (trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide. Identification and synthesis of metabolite substances are necessary for subsequent tests of bioavailability, linearity of pharmacokinetics, accumulation, distribution and excretion</description>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://dspace.bsuedu.ru/handle/123456789/62662">
    <title>Effects of kappa-opioid agonist U-50488 and p38 MAPK inhibitor SB203580 on the spike activity of pyramidal neurons in the basolateral amygdala</title>
    <link>http://dspace.bsuedu.ru/handle/123456789/62662</link>
    <description>Title: Effects of kappa-opioid agonist U-50488 and p38 MAPK inhibitor SB203580 on the spike activity of pyramidal neurons in the basolateral amygdala
Authors: Kalitin, K. V.; Spasov, A. A.; Mukha, O. Y.
Abstract: Our study found that the KOR agonist-induced spiking activity of the BLA pyramidal neurons is mediated by the beta-arrestin pathway and can be suppressed by the application of the p38 MAPK inhibitor SB203580</description>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

